Contact

All Stories

  1. How patients are helping cancer researchers to ask better questions – and find better answers

    Article • November 2025, The Conversation

    Associate Professor James A.L. Brown

  2. Healthcare costs and health outcomes analysis of Neoadjuvant Trastuzumab therapy for HER2 positive breast cancer.

    Article • Cancer Pathogenesis and Therapy, September 2025, Elsevier

    Associate Professor James A.L. Brown

  3. Assessing the clinical utility of pre-operative neutrophil–lymphocyte ratio as a predictor of clinicopathological parameters in patients being treated for primary breast cancer

    Article • Breast Cancer Research and Treatment, January 2025, Springer Science + Business Media

    Associate Professor James A.L. Brown

  4. Acylases

    Article • January 2025, Springer Science + Business Media

    Associate Professor James A.L. Brown

  5. Evaluating the Cellular Roles of the Lysine Acetyltransferase Tip60 in Cancer: A Multi-Action Molecular Target for Precision Oncology

    Article • Cancers, July 2024, MDPI AG

    Associate Professor James A.L. Brown

  6. Current trends in clinical trials and the development of small molecule epigenetic inhibitors as cancer therapeutics

    Article • Epigenomics, April 2024, Taylor & Francis

    Associate Professor James A.L. Brown

  7. Acylases

    Article • January 2024, Springer Science + Business Media

    Associate Professor James A.L. Brown

  8. Profiling leadership: Attitudes, knowledge and training in the biological sciences

    Article • PLOS One, June 2023, PLOS

    Associate Professor James A.L. Brown

  9. Peripheral Blood Cell Ratios as Prognostic Indicators in a Neoadjuvant Chemotherapy-Treated Breast Cancer Cohort

    Article • October 2022, MDPI AG

    Associate Professor James A.L. Brown

  10. Editorial: Mechanisms guarding the genome

    Article • Frontiers in Cell and Developmental Biology, August 2022, Frontiers

    Associate Professor James A.L. Brown

  11. “Centrosome Amplification promotes cell invasion via cell-cell contact disruption and Rap-1 activation”

    Article • May 2022, Cold Spring Harbor Laboratory Press

    Associate Professor James A.L. Brown

  12. Editorial: Cancer Therapeutics: Targeting DNA Repair Pathways

    Article • Frontiers in Molecular Biosciences, February 2022, Frontiers

    Associate Professor James A.L. Brown

  13. Cancer Therapeutics: Targeting DNA Repair Pathways

    Article • January 2022, Frontiers

    Associate Professor James A.L. Brown

  14. Recent Advances in the Role of Discoidin Domain Receptor Tyrosine Kinase 1 and Discoidin Domain Receptor Tyrosine Kinase 2 in Breast and Ovarian Cancer

    Article • Frontiers in Cell and Developmental Biology, November 2021, Frontiers

    Associate Professor James A.L. Brown

  15. A Novel Mechanism of Ataxia Telangiectasia Mutated Mediated Regulation of Chromatin Remodeling in Hypoxic Conditions

    Article • Frontiers in Cell and Developmental Biology, September 2021, Frontiers

    Associate Professor James A.L. Brown

  16. Prospective Assessment of Systemic MicroRNAs as Markers of Response to Neoadjuvant Chemotherapy in Breast Cancer

    Article • Cancers, July 2020, MDPI AG

    Associate Professor James A.L. Brown

  17. Patent spotlight: small-molecule lysine acetyltransferase inhibitors (KATi)

    Article • Pharmaceutical Patent Analyst, January 2020, Future Science

    Associate Professor James A.L. Brown

  18. Quantifying Argonaute 2 (Ago2) expression to stratify breast cancer

    Article • BMC Cancer, July 2019, Springer Science + Business Media

    Associate Professor James A.L. Brown

  19. Recent Advances in Understanding FOXN3 in Breast Cancer, and Other Malignancies

    Article • Frontiers in Oncology, May 2019, Frontiers

    Associate Professor James A.L. Brown

  20. Circulating microRNAs miR-331 and miR-195 differentiate local luminal a from metastatic breast cancer

    Article • BMC Cancer, May 2019, Springer Science + Business Media

    Associate Professor James A.L. Brown

  21. Quantifying Tip60 (Kat5) stratifies breast cancer

    Article • Scientific Reports, March 2019, Springer Science + Business Media

    Associate Professor James A.L. Brown

  22. Large expert-curated database for benchmarking document

    Article • Database, January 2019, Oxford University Press (OUP)

    Dr Daniel Prieto, Associate Professor James A.L. Brown, Professor Amanda G Thrift, Docent Kutty Selva Nandakumar, Professor Miguel Viveiros, MD Diego A. Valera-Cornejo, Dr Soroush Safaei, Dr Carmen San Martín, Piero Carninci, Dr Florian Rehfeldt, Dr Yoichi Watanabe, Kazuki Ide, Mr Alvin Wong, PD Dr. Adrian Meule, Dr Maurizio Petrelli, Dr Christine McGarrigle, Dr Tristan Reddan, Dr Nicola Roberts, Professor Stefan Lorkowski, Dr Cyrille Goarant, Dr Emma C Hobbs, Dr. Saurab Sharma, Ph.D., Dr Farid Rahimi, Prof. Iseult Lynch, Mirella Walker, Dr Luca Galluzzi, Sophie Ohlsson, Professor Tullio Florio, Dr Rabea A Gadelkareem, Dr Azubuike Christian Ukubuiwe, Prof Gajendra PS Raghava, Prof Jun Shen, Lubna Razak, ABHISHEKA BANSAL, Craig Billington, Dr Alejandro Lazo-Langner, Joan Albiol, MOURAD TAYEBI, Chuang Ma, Christine Toelzer , Dr. Kathrin Karsay, Professor Andrew M Beale, Professor Hugh James Byrne, Dr Ugo Marzocchi, Ana Nordberg, Martin Bartas, Natalia Echeverría, Dr Patricia M Graves

  23. Producing scientific posters, using online scientific resources, improves applied scientific skills in undergraduates

    Article • Journal of Biological Education, November 2018, Taylor & Francis

    Associate Professor James A.L. Brown

  24. Clinically Applicable Inhibitors Impacting Genome Stability

    Article • Molecules, May 2018, MDPI AG

    Associate Professor James A.L. Brown

  25. Correction to: Breast cancer subtype discordance: impact on post-recurrence survival and potential treatment options

    Article • BMC Cancer, March 2018, Springer Science + Business Media

    Associate Professor James A.L. Brown

  26. Breast cancer subtype discordance: impact on post-recurrence survival and potential treatment options

    Article • BMC Cancer, February 2018, Springer Science + Business Media

    Associate Professor James A.L. Brown

  27. In Vitro Histone Acetylation Assay

    Article • December 2017, Wiley

    Associate Professor James A.L. Brown

  28. Advances in Precision Medicine: Tailoring Individualized Therapies

    Article • Cancers, October 2017, MDPI AG

    Associate Professor James A.L. Brown

  29. Differential impact of hormone receptor status on survival and recurrence for HER2 receptor-positive breast cancers treated with Trastuzumab

    Article • Breast Cancer Research and Treatment, April 2017, Springer Science + Business Media

    Associate Professor James A.L. Brown

  30. General poster session

    Article • Irish Journal of Medical Science (1971 -), March 2017, Springer Science + Business Media

    Associate Professor James A.L. Brown

  31. Circulating Nucleosomes and Nucleosome Modifications as Biomarkers in Cancer

    Article • Cancers, January 2017, MDPI AG

    Associate Professor James A.L. Brown

  32. Screening of exosomal microRNAs from colorectal cancer cells

    Article • Cancer Biomarkers, January 2017, IOS Press

    Associate Professor James A.L. Brown

  33. Practical Bioinformatics Analysis of MiRNA Data Using Online Tools

    Article • November 2016, Springer Science + Business Media

    Associate Professor James A.L. Brown

  34. Big Data–Led Cancer Research, Application, and Insights

    Article • Cancer Research, October 2016, American Association for Cancer Research (AACR)

    Associate Professor James A.L. Brown

  35. Targeting cancer using KAT inhibitors to mimic lethal knockouts

    Article • Biochemical Society Transactions, August 2016, Portland Press Ltd.

    Associate Professor James A.L. Brown

  36. Evaluating the effectiveness of a practical inquiry‐based learning bioinformatics module on undergraduate student engagement and applied skills

    Article • Biochemistry and Molecular Biology Education, May 2016, Wiley

    Associate Professor James A.L. Brown

  37. Exploring circulating micro-RNA in the neoadjuvant treatment of breast cancer

    Article • International Journal of Cancer, January 2016, Wiley

    Associate Professor James A.L. Brown

  38. Freyer Meeting on 4th and 5th September abstract

    Article • Irish Journal of Medical Science (1971 -), September 2015, Springer Science + Business Media

    Associate Professor James A.L. Brown

  39. ROCK activity and the Gβγ complex mediate chemotactic migration of mouse bone marrow-derived stromal cells

    Article • Stem Cell Research & Therapy, July 2015, Springer Science + Business Media

    Associate Professor James A.L. Brown

  40. Effects of Age on the Detection and Management of Breast Cancer

    Article • Cancers, May 2015, MDPI AG

    Associate Professor James A.L. Brown

  41. Abstract P4-07-05: Exosome-mediated trafficking of microRNAs by breast cancer cells

    Article • Cancer Research, May 2015, American Association for Cancer Research (AACR)

    Associate Professor James A.L. Brown

  42. Patey Prize Papers

    Article • BJS, April 2015, Oxford University Press (OUP)

    Associate Professor James A.L. Brown

  43. Evolution of a research field—a micro (RNA) example

    Article • PeerJ, March 2015, PeerJ

    Associate Professor James A.L. Brown

  44. Metastatic breast cancer: the potential of miRNA for diagnosis and treatment monitoring

    Article • Cancer and Metastasis Reviews, February 2015, Springer Science + Business Media

    Associate Professor James A.L. Brown

  45. Primary cilium-associated genes mediate bone marrow stromal cell response to hypoxia

    Article • Stem Cell Research, September 2014, Elsevier

    Associate Professor James A.L. Brown

  46. Faculty of 1000 evaluation for Primary cilia disassembly down-regulates mechanosensitive hedgehog signalling: a feedback mechanism controlling ADAMTS-5 expression in chondrocytes.

    Article • July 2014, Faculty of 1000, Ltd.

    Associate Professor James A.L. Brown

  47. Rational design and validation of a Tip60 histone acetyltransferase inhibitor

    Article • Scientific Reports, June 2014, Springer Science + Business Media

    Professor Noel F. Lowndes, Associate Professor James A.L. Brown

  48. Faculty of 1000 evaluation for Interleukin-1β sequesters hypoxia inducible factor 2α to the primary cilium.

    Article • February 2014, Faculty of 1000, Ltd.

    Associate Professor James A.L. Brown

  49. Faculty of 1000 evaluation for Surface topography regulates wnt signaling through control of primary cilia structure in mesenchymal stem cells.

    Article • January 2014, Faculty of 1000, Ltd.

    Associate Professor James A.L. Brown

  50. Faculty of 1000 evaluation for Primary cilia: the chemical antenna regulating human adipose-derived stem cell osteogenesis.

    Article • November 2013, Faculty of 1000, Ltd.

    Associate Professor James A.L. Brown

  51. Smg1 haploinsufficiency predisposes to tumor formation and inflammation

    Article • Proceedings of the National Academy of Sciences, December 2012, Proceedings of the National Academy of Sciences

    Associate Professor James A.L. Brown

  52. Multiple Facets of the DNA Damage Response Contribute to the Radioresistance of Mouse Mesenchymal Stromal Cell Lines

    Article • Stem Cells, December 2012, Oxford University Press (OUP)

    Rhodri Ceredig, Professor Noel F. Lowndes, Associate Professor James A.L. Brown

  53. Co‐mutation of histone H2AX S139A with Y142A rescues Y142A‐induced ionising radiation sensitivity

    Article • FEBS Open Bio, January 2012, Wiley

    Professor Noel F. Lowndes, Associate Professor James A.L. Brown

  54. A Novel Role for hSMG-1 in Stress Granule Formation

    Article • Molecular and Cellular Biology, September 2011, ASM Journals

    Associate Professor James A.L. Brown

  55. MCPH1/BRIT1 limits ionizing radiation-induced centrosome amplification

    Article • Oncogene, July 2010, Nature

    Associate Professor James A.L. Brown

  56. DNA damage induces Chk1-dependent threonine-160 phosphorylation and activation of Cdk2

    Article • Oncogene, October 2009, Nature

    Associate Professor James A.L. Brown